Policy Paper: Decision No 1/2026 of the Specialised Committee on Participation in Union Programmes Under the Trade and Cooperation Agreement, Amending Protocol I of the Trade and Cooperation Agreement

Why It Matters

The amendment secures predictable access for UK entities to valuable EU programme funding, bolstering cross‑border research and innovation post‑Brexit. It also reduces regulatory uncertainty, encouraging private investment and collaboration across the Atlantic.

Key Takeaways

• Amends Protocol I to streamline UK participation in EU programmes
• Introduces new eligibility criteria for UK research institutions
• Creates joint oversight committee for programme monitoring
• Secures continuity of EU funding for UK projects post‑Brexit
• Provides legal certainty for UK entities accessing Union programmes

Pulse Analysis

The EU‑UK Trade and Cooperation Agreement, signed in 2020, established a limited but vital conduit for the United Kingdom to remain involved in European Union programmes. Protocol I specifically addresses participation in Union initiatives ranging from Horizon Europe to the EU Green Deal. Since the Brexit transition, both sides have grappled with administrative friction and legal ambiguities that have hampered UK researchers and businesses seeking EU funding. Decision No 1/2026 represents the latest effort to refine that framework, ensuring the UK can continue to tap into the continent’s research ecosystem without a full‑membership status.

Decision No 1/2026 introduces a suite of procedural updates. It clarifies eligibility thresholds for UK‑based entities, aligning them with EU standards to prevent mismatched applications. A newly created joint oversight committee, comprising representatives from the European Commission and the UK Department for Business and Trade, will monitor programme compliance and resolve disputes swiftly. The amendment also codifies a funding continuity clause, guaranteeing that projects approved before the amendment will receive their full allocations, thereby protecting ongoing research pipelines from disruption.

For the broader business and technology landscape, the amendment signals a stable, long‑term partnership that can attract private capital to collaborative ventures. Legal certainty reduces risk for venture‑backed startups and multinational firms that rely on EU grants for R&D. Moreover, the streamlined process is likely to accelerate innovation cycles in sectors such as clean energy, digital health, and advanced manufacturing. As the UK seeks to position itself as a global innovation hub, maintaining robust ties to EU programmes will be a cornerstone of its strategy, fostering talent exchange and market access across the continent.